The development of a home-based therapeutic platform for multiple myeloma

CONCLUSION: We have enabled large numbers of patients to receive complex therapies in their own home and the COVID-19 pandemic has increased the pace of the roll out without any compromise in safety. We anticipate that the next raft of immunotherapies will be able to transition into the @Home treatment setting in the coming years.PMID:34936527 | DOI:10.1080/17474086.2021.2022471

Source: Expert Review of Hematology - December 22, 2021 Category: Hematology Authors: Hayley Beer David Routledge Trish Joyce Emma-Jane Furphy Nella Combe David Ritchie Amit Khot Seok Ming Lim Michael Montalto Simon J Harrison Source Type: research